title: Impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein.
authors.forename: Pierre
authors.initials: P
authors.lastname: Delanaye
authors.forename: Bernard E
authors.initials: BE
authors.lastname: Dubois
authors.forename: Pierre
authors.initials: P
authors.lastname: Lukas
authors.forename: Pierre
authors.initials: P
authors.lastname: Peters
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Krzesinski
authors.forename: Hans
authors.initials: H
authors.lastname: Pottel
authors.forename: Etienne
authors.initials: E
authors.lastname: Cavalier
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D002135:Calcium-Binding Proteins / Q000032:analysis*; D016326:Extracellular Matrix Proteins / Q000032:analysis*; D006801:Humans; D008297:Male; D006435:Renal Dialysis; D012307:Risk Factors; D061205:Vascular Calcification / Q000175:diagnosis / Q000188:drug therapy*; D014812:Vitamin K / Q000037:antagonists & inhibitors*; D000097568:Matrix Gla Protein
chemical_list: D000925:Anticoagulants; D002135:Calcium-Binding Proteins; D016326:Extracellular Matrix Proteins; D014812:Vitamin K; D000097568:Matrix Gla Protein